Want to win a new Alienware 15 R3 laptop with a 15.6-inch IPS display with an anti-glare coating. Under the hood, you will ...

Gaming Laptop. How does it shape up? Read the full review here: <a href=" Asus ROG G752VS-XB78K OC Edition Specs: Intel Core i7-6820HK 3.8GHz 4C/8T 64GB DDR4-2400MHz dual channel 512GB Toshiba XG3 ...

Oct. 26 (UPI) --Chip-maker Nvidia on Friday briefly became the world's most valuable company after surpassing Apple in total market value, but Apple regained its top position by the close of trading.

Nvidia plans to report earnings on Nov. 20 and has forecast double-digit revenue growth. The company is also moving closer to the launch of its potentially game-changing Blackwell architecture ...

Oct 25 (Reuters) - Nvidia (NVDA.O), opens new tab dethroned Apple (AAPL.O), opens new tab as the world's most valuable company on Friday following a record-setting rally in the stock, powered by ...

Nvidia briefly eclipsed Apple to become the world's most valuable company on Friday. It's the first time Nvidia has been the world's largest company since mid-June. Nvidia stock jumped as much as ...

Nvidia dethroned has Apple as the world's most valuable company, following a record-setting rally in the stock powered by an insatiable demand for its new super-computing AI chips. Nvidia's stock ...

Nvidia's market cap leapfrogs Apple, signaling a new titan in tech. AI supercomputing chips fuel Nvidia's stock surge, hinting at the future of tech dominance. What Happened: On Friday, Nvidia’s ...

a launcher that includes the games Call of Duty: Modern Warfare III and Call of Duty: Warzone (available on Xbox and PC Game Pass). The new GeForce Now release list includes: ...

Nvidia's latest Game Ready GeForce driver (566.03) is out and should optimise your rig for some new and upcoming games and DLC, but Corsair iCUE or Bluestacks users might want to hold off on ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.